These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2690101)

  • 1. The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation.
    Reisberg B; Ferris SH; de Leon MJ; Kluger A; Franssen E; Borenstein J; Alba RC
    Prog Clin Biol Res; 1989; 317():23-41. PubMed ID: 2690101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive symptoms in Alzheimer's disease: natural course and temporal relation to function and cognitive status.
    Holtzer R; Scarmeas N; Wegesin DJ; Albert M; Brandt J; Dubois B; Hadjigeorgiou GM; Stern Y
    J Am Geriatr Soc; 2005 Dec; 53(12):2083-9. PubMed ID: 16398891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living alone with Alzheimer's disease: cross-sectional and longitudinal analysis in the REAL.FR Study.
    Nourhashemi F; Amouyal-Barkate K; Gillette-Guyonnet S; Cantet C; Vellas B;
    J Nutr Health Aging; 2005; 9(2):117-20. PubMed ID: 15791356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural networks for longitudinal studies in Alzheimer's disease.
    Tandon R; Adak S; Kaye JA
    Artif Intell Med; 2006 Mar; 36(3):245-55. PubMed ID: 16427257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal models of growth and survival applied to the early detection of Alzheimer's disease.
    McArdle JJ; Small BJ; Bäckman L; Fratiglioni L
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):234-41. PubMed ID: 16306246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of cognitive change from preclinical to clinical Alzheimer's disease.
    Jones S; Small BJ; Fratiglioni L; Backman L
    Brain Cogn; 2002 Jul; 49(2):210-3. PubMed ID: 15259392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced soluble CD40 ligand and Alzheimer's disease: evidence of a possible pathogenetic role.
    Desideri G; Cipollone F; Necozione S; Marini C; Lechiara MC; Taglieri G; Zuliani G; Fellin R; Mezzetti A; di Orio F; Ferri C
    Neurobiol Aging; 2008 Mar; 29(3):348-56. PubMed ID: 17123665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
    Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
    Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD.
    Fotenos AF; Snyder AZ; Girton LE; Morris JC; Buckner RL
    Neurology; 2005 Mar; 64(6):1032-9. PubMed ID: 15781822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of progression in Alzheimer's disease correlates with coated-platelet levels--a longitudinal study.
    Prodan CI; Ross ED; Vincent AS; Dale GL
    Transl Res; 2008 Sep; 152(3):99-102. PubMed ID: 18774538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Alzheimer disease risk by functional magnetic resonance imaging.
    Fleisher AS; Houston WS; Eyler LT; Frye S; Jenkins C; Thal LJ; Bondi MW
    Arch Neurol; 2005 Dec; 62(12):1881-8. PubMed ID: 16344346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute versus chronic pain treatment in Alzheimer's disease.
    Pickering G; Jourdan D; Dubray C
    Eur J Pain; 2006 May; 10(4):379-84. PubMed ID: 16087372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
    Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases.
    Lambon Ralph MA; Patterson K; Graham N; Dawson K; Hodges JR
    Brain; 2003 Nov; 126(Pt 11):2350-62. PubMed ID: 12876147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.
    Kanai M; Matsubara E; Isoe K; Urakami K; Nakashima K; Arai H; Sasaki H; Abe K; Iwatsubo T; Kosaka T; Watanabe M; Tomidokoro Y; Shizuka M; Mizushima K; Nakamura T; Igeta Y; Ikeda Y; Amari M; Kawarabayashi T; Ishiguro K; Harigaya Y; Wakabayashi K; Okamoto K; Hirai S; Shoji M
    Ann Neurol; 1998 Jul; 44(1):17-26. PubMed ID: 9667589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal assessment of deficit unawareness in Alzheimer's disease.
    Vasterling JJ; Seltzer B; Watrous WE
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jul; 10(3):197-202. PubMed ID: 9297713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.